Primary Job Title President Primary Organization 
Roark Rearden & Hamot Capital Management
Gender Male
Investor Type Investor Stage
Mr. Hamot has served as a Director since August 2012. He is the President of Roark, Rearden & Hamot LLC, the general partner of investment fund Costa Brava Partnership III L.P.
Mr. Hamot currently serves as the Chairman of the boards of Spy, Inc., a designer and distributor of premium sunglasses and goggles sold internationally, and ISC8,
Inc.
Previously, Mr. Hamot served as Chairman of the board of Bradley Pharmaceuticals, a specialty pharmaceutical company with products focused on the dermatology and gastroenterology markets.
Mr. Hamot was also the Chairman of the board of TechTeam Global, Inc., a leading provider of IT outsourcing and business process outsourcing services to large and medium businesses, as well as government organizations.
Mr. Hamot also served as a director of CCA Industries, Inc. and has served on both official and ad hoc creditor committees for many companies.
Mr. Hamot has a degree in Economics from Princeton University.
